Search results for "Implantable defibrillator"

showing 4 items of 4 documents

European Clinical Experience with a Dual Chamber Single Pass Sensing and Pacing Defibrillation Lead

2002

Dual chamber ICDs are increasingly implanted nowadays, mainly to improve discrimination between supraventricular and ventricular arrhythmias but also to maintain AV synchrony in patients with bradycardia. The aim of this study was to investigate a new single pass right ventricular defibrillation lead capable of true bipolar sensing and pacing in the right atrium and integrated bipolar sensing and pacing in the right ventricle. The performance of the lead was evaluated in 57 patients (age 61 +/- 12 years; New York Heart Association 1.9 +/- 0.6, left ventricular ejection fraction 0.38 +/- 0.15) at implant, at prehospital discharge, and during a 1-year follow-up. Sensing and pacing behavior of…

MaleBradycardiaTachycardiaPacemaker Artificialmedicine.medical_specialtyDefibrillationHeart Ventriclesmedicine.medical_treatmentImplantable defibrillatorElectrocardiographyInternal medicineTachycardia SupraventricularmedicineHumansHeart AtriaProspective Studiescardiovascular diseasesLead (electronics)AgedEjection fractionbusiness.industryP waveGeneral MedicineMiddle AgedDefibrillators ImplantableElectrodes ImplantedEuropemedicine.anatomical_structureVentricleVentricular Fibrillationcardiovascular systemCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessPacing and Clinical Electrophysiology
researchProduct

Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: resu…

1999

Whether the safety and efficacy of implantable cardioverter defibrillator (ICD) therapy can be assured with lower output devices is an important question. The purpose of this study was to evaluate whether programming the device output at twice the augmented defibrillation threshold was as safe and effective as using the maximum energy. Patients indicated for ICD therapy, but without slow monomorphic ventricular tachycardia (MVT), who achieved an augmented defibrillation threshold (DFT plus)or = 15 joules (J) with a single endocardial lead system and a biphasic defibrillator were included in the study. Prior to ICD implantation, patients were randomized into 2 groups. The shock energies in t…

AdultMalemedicine.medical_specialtyDefibrillationTest groupmedicine.medical_treatmentImplantable defibrillatorDefibrillation thresholdElectrocardiographyLow energyInternal medicineMedicineHumansProspective StudiesAgedEjection fractionEquipment Safetybusiness.industryMiddle AgedImplantable cardioverter-defibrillatorDefibrillators ImplantableSurvival RateTreatment OutcomeShock (circulatory)Ventricular FibrillationCardiologyTachycardia VentricularFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessSoftwareThe American journal of cardiology
researchProduct

Comparative analysis in terms of computational cost for different discrimination algorithms in implantable defibrillators

2005

Implantable defibrillators (ICDs) use very low computational cost criteria (rate, stability and onset) offering good sensitivity for arrhythmia detection. Although, the specificity of these combined criteria decreases in difficult arrhythmia discrimination as in case of discrimination between ventricular tachycardia (VT) and supraventricular tachycardia (SVT). Several morphological published algorithms enhance arrhythmia discrimination but most algorithms are developed in personal computers and cannot be used in ICDs because of computational cost requirements compared with limited ICD capabilities. A general method to determine the possibility of ICD implementation for a discrimination algo…

Arrhythmia detectionGeneral methodbusiness.industrycardiovascular systemStability (learning theory)Medicinecardiovascular diseasesSupraventricular tachycardiabusinessmedicine.diseaseVentricular tachycardiaAlgorithmImplantable defibrillatorsComputers in Cardiology, 2004
researchProduct

[Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective…

1999

The aim of this prospective and randomized study was to evaluate the safety and efficacy of a reduced shock strength in transvenous implantable defibrillator therapy. So far clinical data concerning the safety margin of the shock energy in ICD therapy do not exist. The shock energy tested during long-term follow-up in this study was twice the intraoperatively measured defibrillation threshold (DFT). A total number of 176 consecutive patients representing a typical cohort of ICD patients were evaluated. All patients received a non-thoracotomy lead system (CPI, Endotak 0070, 0090) and a biphasic cardioverter-defibrillator with the ability to store episodes (Cardiac Pacemakers Inc., Ventac TM …

inorganic chemicalsMalemedicine.medical_specialtyDefibrillationmedicine.medical_treatmentElectric CountershockImplantable defibrillatorAmiodaroneSudden cardiac deathlaw.inventionDefibrillation thresholdIntraoperative PeriodRandomized controlled triallawInternal medicinemedicineHumansProspective StudiesEquipment Safetybusiness.industryMiddle Agedmedicine.diseaseSurgeryDefibrillators ImplantableShock (circulatory)Ventricular fibrillationCardiologymedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugFollow-Up StudiesZeitschrift fur Kardiologie
researchProduct